Fall-Winter Visiting Professor lineup features experts in lung, muscle and nerve disorders
The Fall 2013 schedule of Taubman Institute Visiting Professor Lectures, which are held in conjunction with departments of the University of Michigan Medical School, features distinguished scientists from institutions around the world, who have been invited by Taubman Scholars and other faculty members to address the U-M community.
Visiting Professor Lectures are generally held monthly and represent the Taubman Institute's ongoing commitment to furthering translational medical research by creating opportunities for the most talented physician-researchers to exchange knowledge and ideas.
Upcoming events in 2013 include:
Oct. 17: Jann Sarkaria, M.D., of the Mayo Clinic, whose research targets the fatal brain tumor glioblastoma.
Oct: 21: Kurt Stenmark, M.D., a pediatric pulmonology expert from the University of Colorado Denver.
Oct. 23 Andrew Mammen, M.D., Ph.D., whose research targets muscle diseases such as myositis, from the Johns HopkinsSchool of Medicine.
Mar. 19, 2014 Steven A. Goldman M.D., Ph.D., an expert in neurodegenerative diseases from the University of Rochester Medical Center.
More information about each lecture will be posted as it becomes available.
Click here to view video interviews of past visiting professors.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.